Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Socioeconomic status and hepatocellular carcinoma in the United States.

Shebl FM, Capo-Ramos DE, Graubard BI, McGlynn KA, Altekruse SF.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1330-5. doi: 10.1158/1055-9965.EPI-12-0124. Epub 2012 Jun 5.

2.

Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.

Altekruse SF, Henley SJ, Cucinelli JE, McGlynn KA.

Am J Gastroenterol. 2014 Apr;109(4):542-53. doi: 10.1038/ajg.2014.11. Epub 2014 Feb 11.

3.

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Altekruse SF, McGlynn KA, Reichman ME.

J Clin Oncol. 2009 Mar 20;27(9):1485-91. doi: 10.1200/JCO.2008.20.7753. Epub 2009 Feb 17.

4.

Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) Registries.

Kish JK, Yu M, Percy-Laurry A, Altekruse SF.

J Natl Cancer Inst Monogr. 2014 Nov;2014(49):236-43. doi: 10.1093/jncimonographs/lgu020.

5.

Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.

Artinyan A, Mailey B, Sanchez-Luege N, Khalili J, Sun CL, Bhatia S, Wagman LD, Nissen N, Colquhoun SD, Kim J.

Cancer. 2010 Mar 1;116(5):1367-77. doi: 10.1002/cncr.24817.

6.

Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.

Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ.

Arch Surg. 2010 Dec;145(12):1158-63. doi: 10.1001/archsurg.2010.272.

PMID:
21173289
7.

Epidemiology of hepatocellular carcinoma in Hispanics in the United States.

El-Serag HB, Lau M, Eschbach K, Davila J, Goodwin J.

Arch Intern Med. 2007 Oct 8;167(18):1983-9.

PMID:
17923599
8.

Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians.

Chang ET, Yang J, Alfaro-Velcamp T, So SK, Glaser SL, Gomez SL.

Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3106-18. doi: 10.1158/1055-9965.EPI-10-0863. Epub 2010 Oct 12.

9.

Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.

Stewart SL, Kwong SL, Bowlus CL, Nguyen TT, Maxwell AE, Bastani R, Chak EW, Chen MS Jr.

World J Gastroenterol. 2016 Oct 14;22(38):8584-8595.

10.

Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California.

Cheng I, Witte JS, McClure LA, Shema SJ, Cockburn MG, John EM, Clarke CA.

Cancer Causes Control. 2009 Oct;20(8):1431-40. doi: 10.1007/s10552-009-9369-0. Epub 2009 Jun 13.

11.

Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.

Ha J, Yan M, Aguilar M, Bhuket T, Tana MM, Liu B, Gish RG, Wong RJ.

Cancer. 2016 Aug 15;122(16):2512-23. doi: 10.1002/cncr.30103. Epub 2016 May 19.

PMID:
27195481
12.

Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.

White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB.

Gastroenterology. 2017 Mar;152(4):812-820.e5. doi: 10.1053/j.gastro.2016.11.020. Epub 2016 Nov 23.

PMID:
27889576
13.

Geographic variation within the United States in the incidence of hepatocellular carcinoma.

Davila JA, Petersena NJ, Nelson HA, El-Serag HB.

J Clin Epidemiol. 2003 May;56(5):487-93.

PMID:
12812824
14.

Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.

Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, Goodman MT, Lynch CF, Schwartz SM, Chen VW, Bernstein L, Gomez SL, Graff JJ, Lin CC, Johnson NJ, Edwards BK.

Cancer Causes Control. 2009 May;20(4):417-35. doi: 10.1007/s10552-008-9256-0. Epub 2008 Nov 12.

15.

Hepatocellular carcinoma incidence in Florida. Ethnic and racial distribution.

Shea KA, Fleming LE, Wilkinson JD, Wohler-Torres B, McKinnon JA.

Cancer. 2001 Mar 1;91(5):1046-51.

PMID:
11251958
16.

Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort.

Setiawan VW, Wei PC, Hernandez BY, Lu SC, Monroe KR, Le Marchand L, Yuan JM.

Cancer. 2016 May 1;122(9):1444-52. doi: 10.1002/cncr.29922. Epub 2016 Feb 24.

17.

Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study.

O'Malley CD, Le GM, Glaser SL, Shema SJ, West DW.

Cancer. 2003 Mar 1;97(5):1303-11.

18.

Time trends in liver cancer mortality, incidence, and risk factors by unemployment level and race/ethnicity, United States, 1969-2011.

Singh GK, Siahpush M, Altekruse SF.

J Community Health. 2013 Oct;38(5):926-40. doi: 10.1007/s10900-013-9703-z.

PMID:
23689953
19.

Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.

Di Bisceglie AM, Lyra AC, Schwartz M, Reddy RK, Martin P, Gores G, Lok AS, Hussain KB, Gish R, Van Thiel DH, Younossi Z, Tong M, Hassanein T, Balart L, Fleckenstein J, Flamm S, Blei A, Befeler AS; Liver Cancer Network.

Am J Gastroenterol. 2003 Sep;98(9):2060-3.

PMID:
14499788
20.

Socioeconomic factors and breast carcinoma in multicultural women.

Baquet CR, Commiskey P.

Cancer. 2000 Mar 1;88(5 Suppl):1256-64. Review.

PMID:
10705364

Supplemental Content

Support Center